Literature DB >> 20673605

Defining acute kidney injury in database studies: the effects of varying the baseline kidney function assessment period and considering CKD status.

Jean-Philippe Lafrance1, Donald R Miller.   

Abstract

BACKGROUND: Existing acute kidney injury (AKI) definitions are not well adapted for database studies, leading to a great variety of methods used in research. Variations in time before hospitalization used to assess baseline kidney function when identifying episodes of AKI may lead to different case samples and mortality risks in database studies, but the magnitude of these effects is not known. STUDY
DESIGN: A retrospective cohort study. SETTINGS & PARTICIPANTS: 1,126,636 veterans hospitalized at least once within the US Department of Veterans Affairs health care system between 2000 and 2005. PREDICTOR: AKI was defined by comparing (using ratio [≥1.5] or difference [increase of 0.3-0.5 mg/dL]) the highest serum creatinine level during hospitalization with the lowest level during 4 different baseline assessment periods (in-hospital only and 3, 6, or 12 months preadmission). OUTCOMES & MEASUREMENTS: In-hospital mortality risk was estimated using multivariable logistic regression models.
RESULTS: Using the ratio definition, the cumulative incidence of AKI ranged from 12.5% (in-hospital only) to 18.3% (12 months preadmission). Newly added cases had milder AKI and lower mortality risk. The discriminative power increased slightly (C statistic increased from 0.846 to 0.855; P = 0.001) by extending the baseline period to at least 3 months. Both the ratio and difference definitions did not perform well in patients with chronic kidney disease stages 4 and 5. LIMITATIONS: Possibility of residual confounding and under-representation of women (4.5%).
CONCLUSIONS: Many additional AKI cases may be identified by extending the baseline assessment period; however, added cases may be less severe with lower mortality risk. The relative strengths of these biases and combined effects of reducing misclassification (identification of more AKI cases) and increasing risk dilution (identifying milder cases) may vary across populations. Consensus regarding how baseline kidney function should be determined in database studies should be reached.
Copyright © 2010 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673605     DOI: 10.1053/j.ajkd.2010.05.011

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  38 in total

1.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

2.  Performance and limitations of administrative data in the identification of AKI.

Authors:  Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 3.  Acute kidney injury: what's the prognosis?

Authors:  Raghavan Murugan; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 4.  Recent advances in acute kidney injury epidemiology.

Authors:  Edward D Siew; Serpil M Deger
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

Review 5.  Linking acute kidney injury to chronic kidney disease: the missing links.

Authors:  Mohammed A Kaballo; Mohamed E Elsayed; Austin G Stack
Journal:  J Nephrol       Date:  2016-12-07       Impact factor: 3.902

6.  Acute kidney injury and mortality in hospitalized patients.

Authors:  Henry E Wang; Paul Muntner; Glenn M Chertow; David G Warnock
Journal:  Am J Nephrol       Date:  2012-04-02       Impact factor: 3.754

7.  [Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities].

Authors:  M Ardenne; P G Reitnauer
Journal:  Arzneimittelforschung       Date:  1975-09

8.  Determining the incidence of drug-associated acute kidney injury in nursing home residents.

Authors:  Steven M Handler; Pui Wen Cheung; Colleen M Culley; Subashan Perera; Sandra L Kane-Gill; John A Kellum; Zachary A Marcum
Journal:  J Am Med Dir Assoc       Date:  2014-05-10       Impact factor: 4.669

9.  Acute Kidney Injury among Hospitalized Children in China.

Authors:  Xin Xu; Sheng Nie; Aihua Zhang; Jianhua Mao; Hai-Peng Liu; Huimin Xia; Hong Xu; Zhangsuo Liu; Shipin Feng; Wei Zhou; Xuemei Liu; Yonghong Yang; Yuhong Tao; Yunlin Feng; Chunbo Chen; Mo Wang; Yan Zha; Jian-Hua Feng; Qingchu Li; Shuwang Ge; Jianghua Chen; Yongcheng He; Siyuan Teng; Chuanming Hao; Bi-Cheng Liu; Ying Tang; Wenjuan He; Pinghong He; Fan Fan Hou
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-04       Impact factor: 8.237

10.  Hospital-acquired acute kidney injury: an analysis of baseline estimated glomerular filtration rate and in-hospital mortality.

Authors:  Yu-Chen Han; Yan Tu; Hong Liu; Ming-Ming Pan; Ri-Ning Tang; Bi-Cheng Liu
Journal:  J Nephrol       Date:  2015-10-25       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.